The dynorphin/kappa opioid receptor system: a new target for the treatment of addiction and affective disorders?
Shippenberg
Toni S
TS
Integrative Neuroscience Section, NIH/NIDA Intramural Research Program, Baltimore, MD, USA. tshippen@intra.nida.nih.gov
D000818:Animals; D001921:Brain / Q000378:metabolism; D004298:Dopamine / Q000378:metabolism; D016503:Drug Delivery Systems; D004399:Dynorphins / Q000502:physiology*; D006801:Humans; D019964:Mood Disorders / Q000188:drug therapy*; D017473:Receptors, Opioid, kappa / Q000502:physiology*; D019966:Substance-Related Disorders / Q000188:drug therapy*
D017473:Receptors, Opioid, kappa; D004399:Dynorphins; D004298:Dopamine